中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples

文献类型:期刊论文

作者Wang, SQ; Huang, SS; Zhao, X; Zhang, QM; Wu, M; Sun, F; Han, G; Wu, DL
刊名INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
出版日期2014
卷号7期号:1页码:184-193
关键词Prostate cancer (PrCa) primary prostate cancer cultures (PPrCC) prostate cancer stem cells (PrCSC) sphere culture
通讯作者Wu, DL (reprint author), Tongji Univ, Dept Urol, Affiliated Tongji Hosp, 389 Xincun Rd, Shanghai 200065, Shanghai, Peoples R China.,ghan@sibs.ac.cn ; wuyy163@126.com
英文摘要This study was to enrich prostate cancer stem cells (PrCSC) from primary prostate cancer cultures (PPrCC). Primary prostate cancer cells were amplified in keratinocyte serum-free medium with epidermal growth factor (EGF) and bovine pituitary extract (BPE), supplemented with leukemia inhibitory factor (LIF), stem cell factor (SCF) and cholera toxin. After amplification, cells were transferred into ultra-low attachment dishes with serum-free DMEM/F12 medium, supplemented with EGF, basic fibroblast growth factor (bFGF), bovine serum albumin (BSA), insulin, and N2 nutrition. Expression of cell-type-specific markers was determined by RT-qPCR and immunostaining. Tumorigenicity of enriched PrCSC was determined by soft agar assay and xenograft assay in NOD/SCID mice. Biopsy samples from 19 confirmed prostate cancer patients were used for establishing PPrCC, and 18 cases (95%) succeeded. Both basal marker (CK5) and luminal markers (androgen receptor and CK8) strongly co-expressed in most of PPrCC, indicating their basal epithelial origin. After amplification under adherent culture condition in vitro, transient amplifying cells were the dominant cells. Sphere formation efficiency (SFE) of passaged PPrCC was about 0.5%, which was 27 times lower than SFE of LNCaP (13.67%) in the same condition. Compared with adherent cells from PPrCC, prostasphere from PPrCC showed up regulated stem cell markers and increased tumorigenic potential in soft-agar assay. However, spheroid cells from PPrCC prostasphere failed to initiate tumor in xenograft assay in 6 months. Thus, PPrCC can be established and amplified from prostate cancer biopsy samples. Our modified sphere culture system can enrich PrCSC from PPrCC.
学科主题Oncology; Pathology
类目[WOS]Oncology ; Pathology
关键词[WOS]PROSPECTIVE IDENTIFICATION ; PROGENITOR/STEM CELLS ; FORM
收录类别SCI
语种英语
WOS记录号WOS:000335226300018
版本出版稿
源URL[http://202.127.25.143/handle/331003/128]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Wang, SQ,Huang, SS,Zhao, X,et al. Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,2014,7(1):184-193.
APA Wang, SQ.,Huang, SS.,Zhao, X.,Zhang, QM.,Wu, M.,...&Wu, DL.(2014).Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY,7(1),184-193.
MLA Wang, SQ,et al."Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 7.1(2014):184-193.

入库方式: OAI收割

来源:上海生物化学与细胞生物学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。